|
|
An in-vitro sensitivity of Ceftizoxime sodium (CZX), a third generation Cephalosporin, using Epocelin® (a product of Fujisawa Pharmaceutical Central Laboratory, Japan), was studied against various bacterial strains isolated from the children with infections hospitalized on the pediatric ward of Hanyang University Hospital during the period from February, 1983 up to June, 1983. And therapeutic responses were observed in 26 pediatric... |
